Glaxosmithkline Plc ADR (GSK)

$40.50 0.00 (0.00%)

19:00 EDT GSK Stock Quote Delayed 30 Minutes

ALEC Stock: 12 Things to Know About Alector as GSK News Sends It Rocketing Higher

By William White, InvestorPlace Writer Jul 2, 2021

Alector (ALEC) stock is rocketing higher on Friday after the biotechnology company announced a partnership with GlaxoSmithKline (GSK).

The 7 Best ESG Stocks to Buy for the Biggest (Socially Responsible) Gains

7 Pharmaceutical Stocks With Dividends in Hand

7 Cheap Stocks That Won’t Be on Discount for Long

More Articles

Volume:

Previous Close -

Market Cap 218.10B

PE Ratio -

EPS -

Volume (Avg. Vol.) 45

Day's Range 40.50 - 40.50

52-Week Range 33.26 - 42.40

Dividend & Yield 2.14 (5.28%)

GSK Stock Predictions, Articles, and Glaxosmithkline Plc ADR News

From InvestorPlace
From the Web

7 High-Yield Dividend Stocks With Enough Earnings to Cover the Dividends

By Mark R. Hake, CFA Mar 29, 2021

These 7 high-yield dividend stocks have yields above 5% and their payout ratios broadly look strong enough to support those dividends.

VIR Stock: Why Vir Biotechnology Is Plunging Today

By Chris MacDonald, InvestorPlace Contributor Mar 3, 2021

VIR stock is plunging on some pretty unfavorable news about a trial being suspended for the company's prospective Covid-19 vaccine.

7 Stocks to Sell for March

By Louis Navellier and the InvestorPlace Research Staff Feb 26, 2021

The market is starting to get volatile again and sector rotation is underway. Clear the decks by dumping these stocks to sell for March.

10 Dividend Stocks Increasing Their Payouts

By Will Ashworth, InvestorPlace Contributor Feb 19, 2021

When it comes to investing in dividend stocks, companies that significantly increase their payouts are more attractive than those with higher yields.

The Best 4 Pharmaceutical Stocks to Buy in Any Climate

By Joel Baglole Jan 22, 2021

Pharmaceutical stocks, such as Moderna and Novavaxsaw their share prices more than double in the last year. However, not all pharmaceutical stocks have their wagons hitched to solving the Covid-19 pandemic. There are many pharmaceutical stocks that are great long-term investments and would be good additions to a portfolio in any environment. Here we look at four such pharmaceutical stocks.

8 Dental Stocks If You Want to Clean Up

By Josh Enomoto, InvestorPlace Contributor Dec 31, 2020

As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.

The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure

By Tezcan Gecgil, InvestorPlace Contributor Dec 8, 2020

Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021.

GlaxoSmithKline and Sanofi Stock Rally on EU Vaccine Deal

By Sarah Smith, Editor, Today's Market Sep 18, 2020

GlaxoSmithKline and Sanofi stock are rallying in early trading on Friday thanks to news they would supply the EU 300 million vaccine doses.

7 Coronavirus Vaccine Stocks to Watch as Approval Nears

By Thomas Niel Sep 14, 2020

Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Inovio (NASDAQ:INO) Johnson & Johnson (NYSE:JNJ) Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX)

5 Hot Stocks to Buy Still Profiting From Social Distancing

By Tezcan Gecgil, InvestorPlace Contributor Sep 11, 2020

Although broader markets may continue to be volatilie in the rest of the year, these five hot stocks to buy should be on your shopping list.

5 High-Yield Drug Stocks That Are Undervalued With Great Upside

By Mark R. Hake, CFA Jul 24, 2020

As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.

3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline

By David Moadel, InvestorPlace Contributor May 8, 2020

Friday's big stock charts feature pharmaceutical-market names that recently posted terrific earnings data.

10 S&P 500 Stocks to Buy Increasing Their Dividends in 2020

By Will Ashworth, InvestorPlace Contributor Apr 13, 2020

A number of S&P 500 companies have already increased their 2020 dividends by 10% or more. Here are 10 stocks to buy among this group.

Amarin Has the Makings for a Gamechanging Product

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Dec 13, 2019

Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.

4 Stocks to Sell and 6 Stocks to Buy on Vaping Fears

By James Brumley, InvestorPlace Feature Writer Sep 26, 2019

Turning Point Brands, Cronos Group and Altria are just some of the stocks to buy or sell here at a pivotal time for vaporizers.

5 Dividend Stocks to Buy From Across the Globe

By Aaron Levitt, InvestorPlace Contributor Jul 3, 2019

With international dividend stocks, valuations are generally better and yields are bigger. Here are five stocks that stand out.

10 Risky (But Rewarding) Small-Cap Stocks to Buy Now

By James Brumley, InvestorPlace Feature Writer Apr 5, 2019

These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.

9 Blue-Chip Stocks That Will Lose You Money

By James Brumley, InvestorPlace Feature Writer Mar 5, 2019

Think all blue-chip stocks are safe buys at any time? Think again. These companies may be about to stumble, if they haven't already.

3 Life Sciences Stocks to Invest In

By Chris Lau, InvestorPlace Contributor Mar 1, 2019

Generic drug companies are on discount for investors who want to buy life sciences stocks. Why, and when will this sector recover?

3 Biopharma Stocks to Buy for Their Robust Dividend Yields

By Tezcan Gecgil, InvestorPlace Contributor Jan 3, 2019

These three biopharma stocks to buy should help investors maintain strength amid any potential chaos in 2019.

Chinese Gaming Stocks Feel the Pain as Regulatory Fears Return

From Barron's Aug 3, 2021

Mask advisories return, Sanofi to buy Translate Bio for $3.2 billion in mRNA push, Goldman Sachs’ junior bankers are getting a nearly 30% raise, and other news to start your day.

Know When To Hold 'Em, Know When To Fold 'Em ...

From Talk Markets Aug 3, 2021

A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.

GlaxoSmithKline Files US Application For Approval Of Its MMR Vaccine

From Benzinga Aug 2, 2021

GlaxoSmithKline Plc (NYSE: GSK) has submitted a marketing application to the FDA seeking approval for PRIORIX for use in active immunization against infection by...

Cannabis Movers & Shakers: BioHarvest Sciences, Green Hygienics, Realm of Caring, Media Central Corp, Al Harrington's Viola

From Benzinga Aug 2, 2021

BioHarvest Sciences Appoints Two Law Firms To Pursue Regulatory Approvals of Its Upcoming Cannabis and Hemp Products ...

GlaxoSmithKline plc (GSK) Q2 2021 Earnings Call Transcript

From The Motley Fool Jul 28, 2021

GSK earnings call for the period ending June 30, 2021.

Barron's Latest Picks And Pans: American Express, GE, GlaxoSmithKline, Intel And More

From Benzinga Aug 1, 2021

This weekend's Barron's offers investors an overlooked way to play the coming infrastructure surge. Other featured articles discuss how to find rising dividends, why some...